ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

OPTI Optibiotix Health Plc

14.75
-0.50 (-3.28%)
05 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -3.28% 14.75 14.50 15.00 15.25 14.50 15.25 68,434 14:37:58
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 5.19 13.91M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 15.25p. Over the last year, Optibiotix Health shares have traded in a share price range of 7.35p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £13.91 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 5.19.

Optibiotix Health Share Discussion Threads

Showing 22676 to 22699 of 147900 messages
Chat Pages: Latest  912  911  910  909  908  907  906  905  904  903  902  901  Older
DateSubjectAuthorDiscuss
02/4/2017
20:59
wonder if there is a record day to qualify for the 'reward' or existing and new shares bought from now will qualify
onedayrodders
02/4/2017
20:48
fair comment elrico, and in fair balance its only a reported comment on a forum not an RNS, so we cannot put any true value on it.

As an investor I would love it to be right, because we all know what happens if its true,looking at other well oversubscribed releases.
Was strong discussion a while back about some institutions wanting more of a holding.
Well for my money I'm going for a clear blue finish this week..anyone against?????

belgrano2
02/4/2017
20:35
I would be careful with quotes attributed to SOH in relation to SkinBioTherapeutics. SOH is NED - I know he feels it inappropriate as NED to discuss the company and Cath is the main person now, not SOH. I am not suggesting the info is wrong or fabricated. Nobody has stated this before, which is a key dynamic and of course, very bullish point.
elrico
02/4/2017
20:08
from a LSE post.

SOH said yesterday in the presentation that skin would float at a £11m cap.
He hoped that when it got to £20m to £30m then he would look to release the value back to Opti shareholders.

Separately he said skin was 3 times over subscribed, so I hope it's not long before this value is realised.

If this is true,with this oversubscription, it underpins the price and makes it a no brainer...any bets gentlemen.

belgrano2
02/4/2017
18:48
The Daily Mail seems to have gone microbiome crazy. Big multi-page supplements in both yesterday's and Today's papers.

Nothing specific to OPTI but great to see increasing media interest as the story goes more and more mainstream.

someuwin
02/4/2017
17:08
If investors are incentivised for 'holding on' to shares then the rerate should be faster than I'd originally anticipated, especially if the larger holders don't sell. With such positive feedback from the investor show, chances are we're on for another blue day tomorrow.
parob
02/4/2017
16:24
My thanks to Griffin and ODR.

Apologies for following the C & P job on your posts.

So, the way I see it now, there'll be a record PERIOD, rather than a record DATE, for when they 'give some of that value back to (OPTI) shareholders'.

'OPTI shareholders will be "rewarded"'..."at some point in the future"...'in an orderly way'.

But now I'm wondering, will the "in specie divi" quoted by TW be actual shares in SBTX or some other instrument?

Whatever. A good move by SOH for long-term shareholder. It certainly may reduce my incentive to trade!

M

marnewton
02/4/2017
15:27
Griffin - Truth be known I didn't spot it because I was not in attendance, a contact that was in attendance had spoken to Luis and asked when products would be available. On the back of this I thought it best to flag the possible confusion before 17th May arrived with excitement, while the detractors shout we have been sold a pup from the rooftops.

Thanks for your help with your notes, greatly appreciated from the Northern slums ;-)

elrico
02/4/2017
15:23
Would just like to add my thanks to those who attended the Investor Show and took the time to post such excellent feedback. It really is very much appreciated by those of us who were unable to go.

Exciting week ahead folks - can't wait! Good luck all.

jestercat2
02/4/2017
14:55
Elrico, good spot and apologies for any confusion. I was intending to convey LP-LDL will be launched and available in products at the Vital Foods show in May 2017, not the 17th of May. I asked when can I buy a product containing LP-LDL, SOH was clear there are distributors etc in place for this launch in May. Which products, markets and platform however is something we will have to wait for an RNS to clarify.
griffin81
02/4/2017
14:45
Woodaido, been looking at bitcoin and Ripple for a while, any reason for choosing Gatehub over the other two options ?
panic investor
02/4/2017
13:26
Chaps & Ladies, OT, worth taking a look at XRP (Ripple digital currency - like Bitcoin but much better). Banks are signing up to it, 3rd largest bank in the world MUFG just came onboard, and Bank of England looking at it. Potentially for real sky rocket, 400% up in the last few days, could do a bitcoin style rise.
How to get involved
hxxps://ripple.com/xrp-portal/how-to-buy-xrp/#gatehub

woodaldo
02/4/2017
10:25
When Griffin mentioned May 17, I think he was meaning May 2017, not May 17th.
parob
02/4/2017
10:07
There has been some great feedback from you guys that attended. Big thanks, well appreciated. Much for the future.

The only concern I have is the date for LP-LDL launch as being 17th May (very specific) not actually being correct and the launch being weeks later. This creates a possible negative window. Where did this date come from? I would imagine a lot of investors will have put this date in their calendar and if there is no product launch, it could appears as though something has gone wrong - we don't want that do we.

elrico
02/4/2017
10:02
Griffin great feedback and thanks for taking the time. :)
1bokke
02/4/2017
07:52
Really appreciate the feedback from yesterday guys - especially like this line from Griffin's feedback:They currently have between 30 and 40 companies actively discussing commercial opportunities.And of course those conversations were started without Per and Christina on board! That number can only increase which should equate to quite frequent commercial announcements in the future.I know we've had to be incredibly patient waiting for deals to come through, but I genuinely believe they'll be worth the wait. It's clear SOH just won't rush into making deals - he wants the best deals for shareholders, for now and the future. He has stated this can be time consuming in the past:(From a DT interview Nov 2016):We see our strain, which we have now trademarked as LP-LDL, as very much the intel inside a range of products for cardio-vascular health across both consumer health and pharma and whilst time-consuming, building multiple deals helps diversify investor risk and if successful will give a far greater shareholder return.Once the skin IPO is out of the way this coming week, we can then look forward to LP-LDL distributor deal announcements and I'm very excited to see what these look like. So much happening over the next few weeks!
parob
01/4/2017
21:44
Griffin81
Truly appreciate the feedback.
Good luck with your investment

I liked the fact you reported SOH said OPTI shareholders will be rewarded.
That's a huge relief to me, I've invested my max in OPTI and I've ran out of cash if we did have to buy the new IPO.
but good luck to those who buy both.

Like another comment above, all this derisking, I feel like I'm going to be part of four companies, so it's sort of, buy one, get three free!

Best share I've ever encountered in 25+ years of investing!

joyjoy13
01/4/2017
21:34
Someuwin, I listened to the presentation by VLG but ran out of time to visit their stand. Checked my notes again, they stated Benecol will have a capsule launch later this year targeting cholesterol. Not sure if it's connected to OPTI (I might be adding 2 plus 2 and getting a Panama 10), but the timing is intriguing.
griffin81
01/4/2017
21:21
The important thing about OPTI sugar is its Calorie Free!
asterix96
01/4/2017
20:52
Re sugars. Another company that I have a stake in is already able to manufacture sugars C5 and C6s equivalent at one fifth the cost of the grown products.
aspex
01/4/2017
19:52
Cheers Griffin.

Did you get to talk to VLG? did they reveal anything about their potential deal with OPTI?

someuwin
01/4/2017
19:25
O/T, my other highlights (in addition to OPTI and SBTX) were:KEFIVLGCPTDISAAUSRONAPHand possibly NIPT - if the litigation gets dropped.VLG (they describe themselves as a SelfCare business, which I think is genius) are releasing a Benecol pill/supplement this year targeting cholesterol reduction. Impressive little company, and this is very coincidental (or it's not coincidental at all.....)
griffin81
01/4/2017
18:55
i will be buying on the 6th when market settles down but still very early in market terms.far better chance of a more steadier investment than chancing
your arm the day before ..often see a retrace after a hype.I want a good steady investment deal, not giving the greedy mm's high spreads.
very interesting week ahead and very confident for all investors here.
bet i'm not alone.

belgrano2
01/4/2017
18:54
The ticker for SkinBio is definitely SBTX, SOH and the SBio team both confirmed separately. A couple of additional comments from the presentation this afternoon: SOH stated that OptiBiotix (Sugar) was the key platform. SkinBio (SBTX) has the potential to be as big as OPTI in its own right and reiterated that they will give some of that value back to shareholders "at some point in the future".They currently have between 30 and 40 companies actively discussing commercial opportunities.Scientific research is ongoing and future areas (potentially) involve bone health, diabetes and multiple additional applications for LP-LDLSOH did mention again the regulatory burden, cost and timescale of AIM was becoming prohibitive for listings and in future they would consider NASDAQ. He mentioned in my chat earlier that company valuations in the US are much higher than Europe and he believed OPTI would be valued at 350 million now if they had listed in New York. Personally I think a duel-listing in the future would be a clever strategic move. And yes I avoided the sweet stand, but only because they ran out.
griffin81
Chat Pages: Latest  912  911  910  909  908  907  906  905  904  903  902  901  Older

Your Recent History

Delayed Upgrade Clock